For high-growth companies, the decision to raise equity on public markets is driven by strategic expansion, but the execution has historically been characterized by regulatory friction. Preparing for an initial public offering (IPO) or secondary placement across the European Union traditionally required extensive documentation, multiple rounds of supervisory review, substantial advisory retainers, and prolonged execution timelines. These hurdles affected issuers of all sizes, proving disproportionately burdensome for small and medium-sized enterprises (SMEs), scale-ups, and technology firms seeking efficient access to European capital markets.

To dismantle these structural barriers and advance the Capital Markets Union EU initiative, European institutions enacted a landmark legislative package anchored by Regulation (EU) 2024/2809, commonly designated as the EU Listing Act. Rather than creating an isolated parallel market, this comprehensive EU capital markets reform modernizes Europe’s foundational legislative pillars:

• Regulation (EU) 2017/1129 (Prospectus Regulation)
• Regulation (EU) No 596/2014 (Market Abuse Regulation or MAR)
• Regulation (EU) No 600/2014 (MiFIR)
• Directive 2014/65/EU (MiFID II)

The regulatory objective is clear: make public financing less costly and administratively predictable for issuers while preserving investor protection.

Legislative scope of the listing act EU and implementation timelines

The Listing Act EU does not discard existing investor safeguards; instead, it recalibrates European listing rules to reflect how corporate issuers raise and deploy capital throughout their operational lifecycle. While the core package formally entered into force in December 2024, its operational application is staggered across key phases.

According to the latest EU Listing Act news and implementation schedules, several standardized prospectus formats took effect in March 2026, while the principal amendments to the Prospectus Regulation, MAR, and MiFID II became directly applicable in June 2026. Consequently, corporate boards planning an IPO, secondary share issuance, or admission to an SME Growth Market must evaluate how these updated EU IPO rules reshape their near-term fundraising timeline.

Overhauling the EU prospectus regulation: proportionality and standardized exemptions

For corporate treasuries and investment banks, amendments to the EU Prospectus Regulation deliver the most immediate cost reductions. Drafting a full prospectus has historically been one of the most capital-intensive phases of a public transaction, driven by accounting restatements, legal diligence, regulatory review iterations, and multi-jurisdictional translation requirements.

The European Listing Act replaces rigid disclosure mandates with a tiered system distinguishing between first-time IPO candidates, seasoned public issuers, SMEs, and secondary follow-on placements.

Standardized exemption thresholds across member states

Under the revised framework, cross-border fragmentation has been substantially addressed. Member States are now aligned around standardized exemption benchmarks: domestic public offers can be exempted from full prospectus requirements up to EUR 12 million (with Member States retaining the discretion to set a lower threshold of EUR 5 million) over a rolling 12-month period, provided cross-border passporting is not required.

This standardization gives growing businesses predictability when structuring pre-IPO convertible rounds, employee share schemes, or localized equity offerings without triggering disproportionate prospectus liabilities.

Mitigating the dilution penalty on secondary follow-on offerings

Public corporations rarely tap capital markets only once; follow-on placements are essential for funding strategic M&A, international expansion, and ongoing R&D. Under the previous regime, seasoned issuers had to prepare exhaustive documentation that largely duplicated information already available to the public through mandatory periodic filings.

The reformed framework addresses this operational inefficiency:

• The prospectus exemption for fungible securities admitted to trading increases from 20% to 30% of the outstanding shares over a rolling 12-month period.
• Companies whose securities have traded continuously on a regulated market or SME Growth Market for at least 18 months can execute follow-on offerings via an EU Follow-on Prospectus—a significantly shorter, standardized document focused strictly on transaction-specific disclosures.

Language practicality and global documentation standards

Cross-border offerings historically incurred substantial translation fees, as national competent authorities demanded full local-language filings. Under the modernized Prospectus Regulation, prospectuses can now be drafted in a single language customary in international finance—predominantly English.

National language translation requirements are primarily confined to the non-technical prospectus summary, drastically compressing regulatory review cycles and lowering advisory expenses for cross-border issuances.

Targeted revisions to MAR and MiFID II: inside information and research liquidity

While prospectus rules govern the mechanics of going public, the Market Abuse Regulation (MAR) and MiFID II regulate ongoing compliance. The reform introduces targeted updates designed to reflect the commercial reality of how public companies operate.

Managing protracted processes under MAR

Major corporate events—such as multi-stage M&A acquisitions, strategic partnerships, and debt refinancings—rarely materialize through a single executive decision. Under previous MAR interpretations, management faced continuous uncertainty regarding whether early-stage preliminary discussions constituted disclosable inside information.

The updated MAR provides practical clarity: where a protracted process involves multiple intermediate steps leading to a definitive transaction, issuers generally need not disclose each milestone. Disclosure focuses on the final, definitive outcome, provided the issuer maintains strict confidentiality and meets statutory conditions for delaying disclosure.

However, if confidentiality is compromised—for instance, through a sufficiently specific market leak—the issuer must immediately assess the situation and publish the inside information without undue delay. This elevates the importance of robust internal confidentiality logs and escalation procedures.

Research unbundling and SME growth market liquidity

Small and mid-cap issuers have historically suffered from a lack of secondary-market visibility and institutional research coverage. To restore liquidity, the revised MiFID II framework loosens research unbundling restrictions by permitting joint payment arrangements for third-party execution and research services.

Furthermore, the legislation establishes clear regulatory safeguards for issuer-sponsored research, allowing growing companies to legitimately commission analytical coverage to stimulate secondary trading without violating anti-inducement regulations.

Strategic implications for high-growth Tech, FinTech, and Web3 issuers

For innovative scale-ups across software-as-a-service (SaaS), artificial intelligence, digital assets, and financial technology, early venture funding and private credit often reach capacity limits during multi-jurisdictional expansion.

The reforms enacted under the EU Listing Act make public capital a viable alternative to late-stage private equity:

• Accelerated Capital Access: Tech firms that require capital injections to fund software releases or acquisitions can execute repeat equity offerings within compressed timeframes using the 30% follow-on exemption.
• Streamlined Page Ceilings: Standardized page limits and focused risk factor disclosures make prospectus drafting more manageable.
• Dual-Class Share Structures: Alongside Directive (EU) 2024/2810, the broader regulatory package encourages Member States to authorize multiple-vote share structures on SME Growth Markets, enabling technical founders to retain strategic corporate control while accessing public liquidity.

Strategic roadmap: practical steps for prospective issuers

To fully capitalize on the revised regulatory architecture, companies evaluating public market access should execute the following preparatory steps:

• Re-evaluate the Capital Raising Strategy: Re-examine whether an IPO, dual-listing, or admission to an SME Growth Market is commercially viable under the expanded follow-on exemptions and standardized prospectus thresholds.
• Map Applicable Prospectus Exemptions: Determine whether the planned offering qualifies for the EUR 12 million domestic exemption or whether the company can deploy an EU Follow-on Prospectus instead of a standard full-form filing.
• Update Internal MAR Governance: Re-engineer internal policies governing inside information, confidential project logs, delayed disclosure escalation protocols, and the tracking of transactions conducted by Persons Discharging Managerial Responsibilities (PDMRs).
• Assess SME Growth Markets: For mid-sized platforms, evaluate whether an MTF registered as an SME Growth Market provides a more proportionate compliance runway before transitioning to a fully regulated market segment.
• Formalize Corporate Governance Structures: Public markets demand transparent oversight; founders should establish compliant board committees, risk management systems, and auditable financial reporting frameworks well before initiating the listing process.

Public capital markets advisory with Manimama Law Firm

Navigating European capital markets and executing compliant corporate transactions requires cross-border legal precision. At Manimama Law Firm, we help high-growth technology enterprises, FinTech platforms, and international corporate groups structure bankable, regulatory-compliant capital access strategies.

Our cross-border regulatory team directly supports your public transactions:

• Advising on IPO readiness, direct admissions to trading, and secondary cross-border offerings across EU Regulated Markets and SME Growth Markets;
• Conducting regulatory mapping to identify and apply available prospectus exemptions and simplified disclosure frameworks;
• Drafting and reviewing prospectuses, offering circulars, and listing documentation in full compliance with Regulation (EU) 2024/2809;
• Implementing internal Market Abuse Regulation (MAR) compliance programs, confidentiality protocols, and escalation policies;
• Structuring corporate governance architectures, dual-class voting mechanisms, and pre-IPO restructurings;
• Providing ongoing regulatory support for post-listing disclosures, transparency reporting, and supervisory engagement.

Contact information

Leave a request, and we will assemble not just candidates, but a team that will work toward a common goal.

If you want to become our client or partner, write to us at support@manimama.eu.

Or use our Telegram @ManimamaBot and we will respond to your request.

Join our Telegram to receive news in a convenient way: Manimama Legal Channel.

Disclaimer: The information provided in this article is intended for general informational purposes only and should not be considered as individual legal advice. For legal assistance tailored to specific circumstances, it is recommended to seek professional legal counsel.